Picture of Biora Therapeutics logo

BIORQ — Biora Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Biora Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 12
for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Biora Therapeutics Inc
is for
a loss of 45 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $10.30​, above​ its last closing price
of $0.59. ​​​

This summary was machine generated August 9 at 11:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Biora Therapeutics

See all news